Cerus (CERS) vs Sight Sciences (SGHT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sight Sciences (SGHT) has outperformed Cerus (CERS) over the past year, gaining 144.1% versus a gain of 35.7%. Over five years, SGHT leads with a -60.6% price change compared with -62.7% for CERS. Sight Sciences is the larger company by market cap ($477.6 million vs $462.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERS | SGHT |
|---|---|---|
| Share price | $2.30 | $8.67 |
| Market cap | $462.50M | $477.61M |
| 1-day change | +0.66% | +2.36% |
| YTD return | +10.68% | +6.81% |
| 1-year return | +35.71% | +144.09% |
| 5-year return | -62.75% | -60.60% |
| EPS (TTM) | $-0.03 | $-0.56 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $3.47 | $9.71 |
| 52-week low | $1.38 | $3.19 |
| Distance from 52-week high | -33.86% | -10.74% |
| Analyst consensus | none | buy |
| Avg. price target upside | +123.53% | +8.42% |
| Average volume | 2.15M | 258.30K |
| Shares outstanding | 201.52M | 55.09M |
| Employees | 261 | 186 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SGHT has outperformed CERS by 108.4 percentage points over the past year.
About Cerus
CERS stock →Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety.
Health Care · Medical/Dental Instruments · 261 employees
About Sight Sciences
SGHT stock →Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye.
Health Care · Medical/Dental Instruments · 186 employees
CERS vs SGHT FAQ
Which is bigger, Cerus or Sight Sciences?
Sight Sciences (SGHT) is larger, with a market capitalization of $477.61M compared with $462.50M for Cerus (CERS).
Which stock has performed better over the past year, CERS or SGHT?
SGHT returned +144.09% over the past 12 months, compared with +35.71% for CERS (price return, excluding dividends). Past performance does not predict future results.
Are Cerus and Sight Sciences in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.